Neurology Learning Network spoke with Sami Khella, MD, who gave a talk on new and emerging therapies for amyloidosis at the American Neurological Association’s 145th Annual Meeting.
Neurology Learning Network spoke with Steven M. Greenberg, MD, PhD, who gave a talk at the American Neurological Association’s 145th Annual Meeting about recent research and treatment advances in cerebral amyloid angiopathy.
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual Meeting.
At the ANA’s 145th Annual Meeting, P. James Dyck, MD, discussed recent research and treatment advances in hereditary transthyretin amyloidosis. After Dr Dyck’s presentation, Neurology Learning Network caught up with him about important research and treatment advances in this field.
In this video, Dr Monje discusses recent evidence regarding the neuronal regulation of the pathobiology of brain tumors and potential implications of this evidence. Dr Monje was presented with an award for this talk at the American Neurological Association’s 145th Annual Meeting.
Using plasma and cerebrospinal fluid samples, researchers investigated a potential biomarker for antibody-mediated autoimmune encephalitis. The findings were presented at the American Neurological Association’s 145th Annual Meeting.
In this video, Peter Calabresi, MD, discusses the findings from his award-winning study, which suggested that inhibiting immune activation of oligodendrocyte precursor cells may foster remyelination among patients with multiple sclerosis. Dr Calabresi and his team will be presented with an award for this study at the American Neurological Association’s 145th Annual Meeting.
In a new study presented at the American Neurological Association’s 145th Annual Meeting, researchers investigated the prevalence of neurological comorbidities among hospitalized patients with opioid abuse.
New findings presented at the American Neurological Association’s 145th Annual Meeting indicated that certain characteristics could predict seizure among a patient population with inpatient stroke codes.